Press Releases

February 2, 2022

Results of the Phase 2 GARDEN study in COVID-19-related acute respiratory distress syndrome and exclusive interview with Acticor Biotech management

Download the press release

For more informations, watch the exclusive interview with Acticor Biotech management:

Navigation
CompanyOur ProductPipelineAbout strokeMedia
Contact Us
ContactFollow us on LinkedInFollow us on TwitterCareers

Acticor Biotech
Wojo Building
82, avenue du Maine
75014 Paris

+33 (0)6 76 23 38 13

© 2021 Acticor Biotech SA
Legal mentionsPrivacy Policy
email:
contact@acticor-biotech.com